$0.42
+0.00 (+0.29%)
Open$0.40
Previous Close$0.42
Day High$0.44
Day Low$0.36
52W High$7.19
52W Low$0.42
Volume—
Avg Volume462.6K
Market Cap9.79M
P/E Ratio—
EPS$-3.23
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+9,522.3% upside
Current
$0.42
$0.42
Target
$40.51
$40.51
$28.40
$40.51 avg
$50.89
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.30M | 6.48M | 4.92M |
| Net Income | -1,316,650 | -1,573,823 | -1,131,717 |
| Profit Margin | -20.9% | -24.3% | -23.0% |
| EBITDA | -2,363,922 | -2,326,744 | -1,866,701 |
| Free Cash Flow | -1,722,588 | -1,580,767 | -1,263,847 |
| Rev Growth | -2.8% | +6.4% | +0.2% |
| Debt/Equity | 0.17 | 0.14 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |